elanco af1404 rumensin 100 monensin sodium
elanco australasia pty ltd - monensin as monensin sodium - oral powder, pre-mix - monensin as monensin sodium antiprotozoal active 100.0 g/kg - nutrition & metabolism - cattle | cattle - feedlot | dairy cattle | goat | pasture cattle | poultry | sheep | | beef | billy | bos indicus | bos taurus - bloat | coccidiosis | improve feed efficiency | improve reproductive performance | improvement of milk production | prevention of coccidiosis | productivity improvements | bloated | coccidiosis - prevention of | colic | eimeria acervulina | eimeria brunetti | eimeria maxima | eimeria mivati | eimeria necatrix | eimeria tenella | frothy bloat | gas colic | improving feed efficiency | increasing rate of weight gain | legume bloat | weight gain
elanco af1300 tylan tylosin tartrate soluble
elanco australasia pty ltd - tylosin as tartrate - oral powder, pre-mix - tylosin as tartrate antibiotic active 800.0 mg/g - antibiotic & related - pigs | poultry broilers (meat for human consum) | pullet - replacement | turkeys | boar | breeder | broiler breeder | chickens | - ileitis | infections of the respiratory tract | infectious sinusitis | swine dysentery | acute respiratory infections | bronchiseptica | bronchitis | discharging sinuses | pharyngitis | pneumonia | tonsillitis
elanco af0250 tylan 250 tylosin phosphate premix
elanco australasia pty ltd - tylosin as the phosphate - oral powder, pre-mix - tylosin as the phosphate antibiotic active 250.0 g/kg - antibiotic & related - cattle | pigs | poultry broilers (meat for human consum) | pullet - replacement | beef | boar | bos indicus | bos taurus | bovin - ileitis | improve feed efficiency | liver abscess | necrotic enteritis | promote animal growth | swine dysentery | feed conversion | finishing | growth promotion | growth rate | liveweight gain
naprelan- naproxen sodium tablet, film coated, extended release
rebel distributors corp - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 375 mg - carefully consider the potential benefits and risks of naprelan® tablets and other treatment options before deciding to use naprelan® tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naprelan® tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan® is contraindicated in patients with known hypersensitivity to naproxen. naprelan® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions , and precautions- preexisting asthma ). naprelan® is contraindicated for the treatment of peri-operative pain in the setting of cor
naprelan- naproxen sodium tablet, film coated, extended release
physicians total care, inc. - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 375 mg - carefully consider the potential benefits and risks of naprelan® tablets and other treatment options before deciding to use naprelan® tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naprelan® tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan® is contraindicated in patients with known hypersensitivity to naproxen. naprelan® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions , and precautions- preexisting asthma ). naprelan® is contraindicated for the treatment of peri-operative pain in the setting of cor
naprelan- naproxen sodium tablet, film coated, extended release
stat rx usa - naproxen sodium (unii: 9tn87s3a3c) (naproxen - unii:57y76r9atq) - naproxen sodium 750 mg - carefully consider the potential benefits and risks of naprelan® tablets and other treatment options before deciding to use naprelan® tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). naprelan® tablets are indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis and acute gout. it is also indicated in the relief of mild to moderate pain and the treatment of primary dysmenorrhea. naprelan® is contraindicated in patients with known hypersensitivity to naproxen. naprelan® should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings- anaphylactoid reactions , and precautions- preexisting asthma ). naprelan® is contraindicated for the treatment of peri-operative pain in the setting of cor
elanco ah0492 extinosad lice, fly and maggot eliminator
elanco australasia pty ltd - spinosad manufacturing concentrate - topical solution/suspension - spinosad manufacturing concentrate ungrouped active 25.0 g/l - parasiticides - sheep | sheep - mulesing wound | sheep - wound | sheep long wool (unshorn) | sheep short wool (shorn) | ewe | hogget | lamb | ov - fly strike | sheep body louse | blowfly strike | body & crutch strike | body strike only | crutch strike | damalinia ovis (prev. genus) | lice - synthetic pyrethroid re | poll strike | sheep body lice
elanco ah0315 rumensin capsule
elanco australasia pty ltd - monensin as monensin sodium - misc. intra ruminal device - monensin as monensin sodium antiprotozoal active 32.0 g/cp - alimentary system - cattle | dairy cattle | beef | bos indicus | bos taurus | bovine | breeders | buffalo | bull | bullock | calf | calves | cow | d - bloat | improvement of milk production | ketosis | productivity improvements | acetonaemia | bloated | colic | elevated ketones | frothy bloat | gas colic | improving feed efficiency | increasing rate of weight gain | legume bloat | non-clinical ketosis | weight gain
elanco ah0973 component te-s with tylan growth and finishing implants for steers
elanco australasia pty ltd - tylosin tartrate; trenbolone acetate; oestradiol - parenteral implant, device - tylosin tartrate antibiotic active 29.0 mg/im; trenbolone acetate steroid-anabolic active 140.0 mg/im; oestradiol steroid-estrogen active 28.0 mg/im - nutrition & metabolism - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - abscess | promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain
elanco ah0338 component-h with tylan growth and finishing implants for heifers
elanco australasia pty ltd - tylosin tartrate; testosterone propionate; oestradiol benzoate - parenteral implant, device - tylosin tartrate antibiotic active 29.0 mg; testosterone propionate steroid-anabolic active 200.0 mg; oestradiol benzoate steroid-estrogen active 20.0 mg - nutrition & metabolism - heifer - abscess | promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain